Science Explorer Back to mapMap
Discussion
Hospital / health system · Omaha · United States

Nebraska Cancer Specialists

nebraskacancer.comROR OpenAlex
Research works
69
▲ 39% vs 2018-21
Citations
1.7k
24.4 per fractional work
Top-10% rate
11.1%
all institutions 10.0%
Open access
32%
world 40%
International
20%
world 18%
Nebraska Cancer Specialists

Not ranked overall: Nebraska Cancer Specialists is under the volume floor below which a citation excellence rate is noise. Not ranked is not the same as ranked last.

Which fields of science does Nebraska Cancer Specialists work in?

In all years, 77% of research at Nebraska Cancer Specialists is in Health Sciences, 20% in Life Sciences. Its largest fields are Medicine (75%), Biochemistry, Genetics and Molecular Biology (15%), Immunology and Microbiology (3%). It does 2.9× the world's share of Health Sciences.

Health Sciences: 53 fractional works · 77.2% of its workMedicine: 52 fractional works · 74.7% of its workOncology: 12 fractional works · 17.5% of its workPulmonary and Respiratory Medicine: 9 fractional works · 13.5% of its workSurgery: 5 fractional works · 6.7% of its workRadiology, Nuclear Medicine and Imaging: 4 fractional works · 6.3% of its workEpidemiology: 4 fractional works · 5.1% of its workPathology and Forensic Medicine: 2 fractional works · 3.4% of its workHematology: 2 fractional works · 3.2% of its workPublic Health, Environmental and Occupational Health: 1 fractional works · 1.9% of its workGenetics: 1 fractional works · 1.6% of its workRheumatology: 1 fractional works · 1.5% of its workOtorhinolaryngology: 1 fractional works · 1.4% of its workDermatology: 1 fractional works · 1.3% of its workEndocrinology, Diabetes and Metabolism: 1 fractional works · 1.3% of its workNeurology: 1 fractional works · 1.3% of its workObstetrics and Gynecology: 1 fractional works · 1.3% of its workGastroenterology: 1 fractional works · 1.1% of its workPhysiology: 1 fractional works · 1.1% of its workCardiology and Cardiovascular Medicine: 1 fractional works · 0.9% of its workInfectious Diseases: 0 fractional works · 0.6% of its workImmunology and Allergy: 0 fractional works · 0.5% of its workReproductive Medicine: 0 fractional works · 0.5% of its workPsychiatry and Mental health: 0 fractional works · 0.4% of its workPharmacology: 0 fractional works · 0.3% of its workInternal Medicine: 0 fractional works · 0.3% of its workNephrology: 0 fractional works · 0.2% of its workHealth Informatics: 0 fractional works · 0.2% of its workSmaller subfields together: 1 fractional works · 1.1% of its workHealth Professions: 2 fractional works · 2.3% of its workGeneral Health Professions: 1 fractional works · 1.2% of its workHealth Information Management: 0 fractional works · 0.4% of its workSpeech and Hearing: 0 fractional works · 0.3% of its workEmergency Medical Services: 0 fractional works · 0.3% of its workSmaller subfields together: 0 fractional works · 0.0% of its workVeterinary: 0 fractional works · 0.3% of its workSmall Animals: 0 fractional works · 0.3% of its workDentistry: 0 fractional works · 0.0% of its workLife Sciences: 14 fractional works · 20.2% of its workBiochemistry, Genetics and Molecular Biology: 11 fractional works · 15.4% of its workMolecular Biology: 6 fractional works · 8.7% of its workCancer Research: 3 fractional works · 4.5% of its workGenetics: 1 fractional works · 1.2% of its workCell Biology: 0 fractional works · 0.6% of its workBiotechnology: 0 fractional works · 0.5% of its workImmunology and Microbiology: 2 fractional works · 2.6% of its workImmunology: 2 fractional works · 2.3% of its workVirology: 0 fractional works · 0.3% of its workAgricultural and Biological Sciences: 1 fractional works · 0.8% of its workPlant Science: 0 fractional works · 0.5% of its workSmaller subfields together: 0 fractional works · 0.2% of its workPharmacology, Toxicology and Pharmaceutics: 1 fractional works · 0.7% of its workPharmacology: 0 fractional works · 0.5% of its workSmaller subfields together: 0 fractional works · 0.2% of its workNeuroscience: 0 fractional works · 0.7% of its workCellular and Molecular Neuroscience: 0 fractional works · 0.7% of its workPhysical Sciences: 1 fractional works · 1.4% of its workEngineering: 0 fractional works · 0.6% of its workBiomedical Engineering: 0 fractional works · 0.4% of its workBuilding and Construction: 0 fractional works · 0.2% of its workPhysics and Astronomy: 0 fractional works · 0.4% of its workRadiation: 0 fractional works · 0.4% of its workSmaller subfields together: 0 fractional works · 0.0% of its workMaterials Science: 0 fractional works · 0.2% of its workMathematics: 0 fractional works · 0.1% of its workChemistry: 0 fractional works · 0.0% of its workSocial Sciences: 1 fractional works · 1.1% of its workPsychology: 0 fractional works · 0.5% of its workClinical Psychology: 0 fractional works · 0.3% of its workSmaller subfields together: 0 fractional works · 0.2% of its workEconomics, Econometrics and Finance: 0 fractional works · 0.4% of its workEconomics and Econometrics: 0 fractional works · 0.4% of its workSocial Sciences: 0 fractional works · 0.2% of its workALL ITS WORKNebraska CancerSpecialists69fractional works, all years
Life Sciences20%Physical Sciences1%Health Sciences77%Social Sciences1%

Each ring splits the one inside it: the four domains of science, their fields, their subfields. Size is fractional works in all years. Every slice is a page; the interactive view zooms down to single topics and colours each by how much more of it this institution does than the world.

Its 4 domains and 17 fields, with their numbers
    1. Medicine5274.7%
    2. Health Professions22.3%
    3. Veterinary00.3%
    4. Dentistry00.0%
    1. Biochemistry, Genetics and Molecular Biology1115.4%
    2. Immunology and Microbiology22.6%
    3. Agricultural and Biological Sciences10.8%
    4. Pharmacology, Toxicology and Pharmaceutics10.7%
    5. Neuroscience00.7%
    1. Engineering00.6%
    2. Physics and Astronomy00.4%
    3. Materials Science00.2%
    4. Mathematics00.1%
    5. Chemistry00.0%
    1. Psychology00.5%
    2. Economics, Econometrics and Finance00.4%
    3. Social Sciences00.2%
All of science, and how each field's share has moved since 1950: the Science domain explorer

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Agricultural and Biological Sciences: 0.04× its world share, 0 worksAgricultural and Bio…Biochemistry, Genetics and Molecular Biology: 2.20× its world share, 2 worksBiochemistry, Geneti…Immunology and Microbiology: 3.25× its world share, 1 worksImmunology and Micro…Pharmacology, Toxicology and Pharmaceutics: 1.13× its world share, 0 worksPharmacology, Toxico…Chemistry: 0.12× its world share, 0 worksChemistryEngineering: 0.01× its world share, 0 worksEngineeringPhysics and Astronomy: 0.05× its world share, 0 worksPhysics and AstronomyHealth Professions: 1.22× its world share, 1 worksHealth ProfessionsMedicine: 4.08× its world share, 14 worksMedicineVeterinary: 4.66× its world share, 0 worksVeterinaryEconomics, Econometrics and Finance: 0.36× its world share, 0 worksEconomics, Econometr…Psychology: 0.12× its world share, 0 worksPsychologySocial Sciences: 0.05× its world share, 0 worksSocial Sciences1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Veterinary, 4.7×. Every wedge is a field page.

All 13 fields, with their numbers
  1. Veterinary4.66×0 works
  2. Medicine4.08×14 works
  3. Immunology and Microbiology3.25×1 works
  4. Biochemistry, Genetics and Molecular Biology2.20×2 works
  5. Health Professions1.22×1 works
  6. Pharmacology, Toxicology and Pharmaceutics1.13×0 works
  7. Economics, Econometrics and Finance0.36×0 works
  8. Chemistry0.12×0 works
  9. Psychology0.12×0 works
  10. Physics and Astronomy0.05×0 works
  11. Social Sciences0.05×0 works
  12. Agricultural and Biological Sciences0.04×0 works
  13. Engineering0.01×0 works

Who are the top researchers at Nebraska Cancer Specialists?

Ranked on the quality score, Ralph J. Hauke, Yungpo Bernard Su and Timothy K. Huyck lead among researchers whose main affiliation is Nebraska Cancer Specialists.

  1. 1 Ralph J. Hauke United States · #105,262 worldwide 6.1k citations · 269 works
  2. 2 Yungpo Bernard Su United States · #802,005 worldwide 4.3k citations · 20 works
  3. 3 Timothy K. Huyck United States · #1,865,837 worldwide 379 citations · 16 works
All ranked researchers at Nebraska Cancer Specialists

What are the most cited papers from Nebraska Cancer Specialists?

The most cited paper from Nebraska Cancer Specialists is "Bruton Tyrosine Kinase Inhibitor Ibrutinib (PCI-32765) Has Significant Activity in Patients With Relapsed/Refractory B-Cell Malignancies" (Ranjana H. Advani, Joseph J. Buggy, Jeff Porter Sharman et al., 2012), with 1,129 citations. Next come "Neratinib after trastuzumab-based adjuvant therapy in patients with HER2-positive breast cancer (ExteNET): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial" (569) and "Combination Dabrafenib and Trametinib Versus Combination Nivolumab and Ipilimumab for Patients With Advanced BRAF-Mutant Melanoma: The DREAMseq Trial—ECOG-ACRIN EA6134" (474).

Most cited papers
#PaperReleasedCitations
1 Bruton Tyrosine Kinase Inhibitor Ibrutinib (PCI-32765) Has Significant Activity in Patients With Relapsed/Refractory B-Cell Malignancies Ranjana H. Advani, Joseph J. Buggy, Jeff Porter Sharman et al. · Journal of Clinical Oncology Open access 9 Oct 2012 1,129
2 Neratinib after trastuzumab-based adjuvant therapy in patients with HER2-positive breast cancer (ExteNET): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial Arlene Chan et al. · The Lancet Oncology 12 Feb 2016 569
3 Combination Dabrafenib and Trametinib Versus Combination Nivolumab and Ipilimumab for Patients With Advanced BRAF-Mutant Melanoma: The DREAMseq Trial—ECOG-ACRIN EA6134 Michael B. Atkins et al. · Journal of Clinical Oncology Open access 27 Sep 2022 474
4 IDH1 mutant malignant astrocytomas are more amenable to surgical resection and have a survival benefit associated with maximal surgical resection Jason Beiko, Dima Suki, Kenneth R. Hess et al. · Neuro-Oncology Open access 4 Dec 2013 470
5 Management of Metastatic Clear Cell Renal Cell Carcinoma: ASCO Guideline W. Kimryn Rathmell, R. Bryan Rumble, Peter J. Van Veldhuizen et al. · Journal of Clinical Oncology 21 Jun 2022 351
All 60 most cited papers, with filters and sorting

Which keywords describe research at Nebraska Cancer Specialists?

By fractional works in all years, weighted toward what it does more of than the world: Immunotherapy, Chemotherapy, Genetic Mutations, Prognostic Factors, Targeted Therapy, Clinical Trials, Biomarkers and PET Imaging.

▲ more of its work than of the world's◆ about the world's share▼ less than the world's

Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 40 words, with their numbers
  1. Immunotherapy9▲ 21×14 topics
  2. Chemotherapy7▲ 14×18 topics
  3. Genetic Mutations6▲ 17×9 topics
  4. Prognostic Factors6▲ 19×10 topics
  5. Targeted Therapy6▲ 38×4 topics
  6. Clinical Trials5▲ 12×5 topics
  7. Biomarkers4▲ 10×4 topics
  8. PET Imaging4▲ 29×4 topics
  9. Cancer4▲ 3.9×24 topics
  10. Tumor Microenvironment4▲ 15×7 topics
  11. Prostate Cancer4▲ 33×4 topics
  12. Molecular Characterization3▲ 26×4 topics
  13. Genomic Profiling3▲ 46×2 topics
  14. Metastasis3▲ 14×8 topics
  15. Cancer Therapy3▲ 6.4×11 topics
  16. Clinical Guidelines3▲ 13×5 topics
  17. Hormone Therapy3▲ 38×2 topics
  18. Cancer Treatment3▲ 14×6 topics
  19. Dosimetry2▲ 40×2 topics
  20. Neoadjuvant Therapy2▲ 16×5 topics
  21. Survival Analysis2▲ 13×5 topics
  22. Therapy2▲ 17×5 topics
  23. Androgen Receptor2▲ 38×1 topic
  24. Metastatic Prostate Cancer2▲ 78×1 topic
  25. Metastatic2▲ 50×2 topics
  26. Radioimmunotherapy2▲ 82×1 topic
  27. Radiopharmaceuticals2▲ 82×1 topic
  28. Breast Cancer2▲ 10×6 topics
  29. Clinical Practice Guidelines2▲ 5.2×9 topics
  30. Rituximab2▲ 17×2 topics
  31. Cancer Incidence2▲ 18×3 topics
  32. Gene Expression Profiling2▲ 27×2 topics
  33. Molecular Profiling2▲ 22×2 topics
  34. Metastatic Breast Cancer2▲ 38×2 topics
  35. Tumor Markers2▲ 35×2 topics
  36. Cancer Risk2▲ 9.1×4 topics
  37. Genomic Profiles2▲ 68×1 topic
  38. Immune Checkpoint Blockade2▲ 42×1 topic
  39. PD-1 and PD-L12▲ 42×1 topic
  40. Small-Cell Lung Cancer2▲ 68×1 topic

Which research topics does Nebraska Cancer Specialists publish most on?

By volume in 2022-now: Radiopharmaceutical Chemistry and Applications, Cancer Immunotherapy and Biomarkers, Prostate Cancer Treatment and Research and Neuroendocrine Tumor Research Advances.

Radiopharmaceutical Chem…1Radiopharmaceutical Chemistry and Applications: 1 fractional worksCancer Immunotherapy and…1Cancer Immunotherapy and Biomarkers: 1 fractional worksProstate Cancer Treatmen…1Prostate Cancer Treatment and Research: 1 fractional worksNeuroendocrine Tumor Res…1Neuroendocrine Tumor Research Advances: 1 fractional worksLung Cancer Research Studies: 1 fractional worksRenal cell carcinoma treatment: 0 fractional worksPalliative Care and End-…0Palliative Care and End-of-Life Issues: 0 fractional worksGeriatric Care and Nursi…0Geriatric Care and Nursing Homes: 0 fractional worksProstate Cancer Diagnosi…0Prostate Cancer Diagnosis and Treatment: 0 fractional worksSinusitis and nasal cond…0Sinusitis and nasal conditions: 0 fractional works
Radiology, Nuclear Medicine and ImagingOncologyPulmonary and Respiratory MedicineEpidemiology3 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 Radiopharmaceutical Chemistry and Applications Radiology, Nuclear Medicine and Imaging 1 works
  2. 2 Cancer Immunotherapy and Biomarkers Oncology 1 works
  3. 3 Prostate Cancer Treatment and Research Pulmonary and Respiratory Medicine 1 works
  4. 4 Neuroendocrine Tumor Research Advances Epidemiology 1 works
  5. 5 Lung Cancer Research Studies Oncology 1 works
  6. 6 Renal cell carcinoma treatment Pulmonary and Respiratory Medicine 0 works
  7. 7 Palliative Care and End-of-Life Issues Public Health, Environmental and Occupational Health 0 works
  8. 8 Geriatric Care and Nursing Homes General Health Professions 0 works
  9. 9 Prostate Cancer Diagnosis and Treatment Pulmonary and Respiratory Medicine 0 works
  10. 10 Sinusitis and nasal conditions Otorhinolaryngology 0 works

How open and international is its research?

Against the world's own shares: the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available32.5%not open67.5%

World: 40% of research is openly available.

with international co-authors19.5%domestic only80.5%

World: 18% is written across borders.

How has Nebraska Cancer Specialists's research output changed?

Output in 2022-2025 was 39% higher than in 2018-2021.

still counting1990200020102020
grewheldshrank

The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.

Its share of all research

Growing output can still be a shrinking share: all of science grows. This is Nebraska Cancer Specialists as a percentage of every work published that year, 0.000058% in 2024.

still counting0.00020%0.00040%0.00060%Nebraska Cancer Specialists0.000073% in 202519801990200020102020

Fractional works of Nebraska Cancer Specialists over all fractional works that year. How the balance of science has shifted.

Other research institutions in Omaha

All research institutions in Omaha

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners have tabs of their own, above.

Discussion

Ask a question or share a note about Nebraska Cancer Specialists. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.